Virtual global biorepository: access for all to speed-up result-oriented research

Kumar, Awanish

doi:10.1007/s10561-020-09830-7

Cited by 4 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, it allows integrations with other software to facilitate access to additional information and speed up all the tasks performed [27]. Currently, nSIBAI is working in more than 20 nodes of the SSPA Biobank, operating as a virtual biobank [28,29]. nSIBAI is organized in different modules that are connected between them.…”

Section: Design Of the Data Model And Their Integration In The Inform...mentioning

confidence: 99%

Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine

Sánchez-López,

Catalina,

Franco

et al. 2024

JPM

View full text Add to dashboard Cite

Biobanks are infrastructures essential for research involving multi-disciplinary teams and an increasing number of stakeholders. In the field of personalized medicine, biobanks play a key role through the provision of well-characterized and annotated samples protecting at the same time the right of donors. The Andalusian Public Health System Biobank (SSPA Biobank) has implemented a global information management system made up of different modules that allow for the recording, traceability and monitoring of all the information associated with the biobank operations. The data model, designed in a standardized and normalized way according to international initiatives on data harmonization, integrates the information necessary to guarantee the quality of results from research, benefiting researchers, clinicians and donors.

show abstract

Section: Design Of the Data Model And Their Integration In The Inform...mentioning

confidence: 99%

Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine

Sánchez-López,

Catalina,

Franco

et al. 2024

JPM

View full text Add to dashboard Cite

show abstract

“…In addition, it allows integrations with other software to facilitate access to additional information and speed up all the tasks performed. Currently, nSIBAI is working in more than 20 nodes of the SSPA Biobank, operating as a virtual biobank [8,9].…”

Section: Database and Management Systemmentioning

confidence: 99%

The Andalusian Registry of Donors for Biomedical Research: Five Years of History

Aguilar-Quesada

Aroca-Siendones

Torre

et al. 2021

BioTech

View full text Add to dashboard Cite

The mission of the Andalusian Public Health System Biobank is to offer the best options for biological samples of human origin and associated clinical information, protecting the rights of citizens who donate their samples for research. Since the Andalusian Biobank provides high-quality biological samples of all types in a specified format, adapting the preanalytical phase according to the requirements of the research, prospective collection and distribution of samples are being prioritized in order to contribute to the sustainability of the Biobank. The Andalusian Registry of Donors for Biomedical Research is a tool for the recruitment of donors and the prospective collection of samples. Its operation is based on the informed consent of donors for their incorporation into the Registry and contact with possible donors under request from specific projects. An additional advantage of this unique initiative is to ensure that societal actors work together throughout the entire research process, establishing alliances with patient associations and groups to develop joint actions and promote biomedical research. Here, we describe the creation, ethical–legal aspects, management and results of the Andalusian Registry of Donors for Biomedical Research after five years of operation.

show abstract

“…Researchers across the globe can seamlessly locate specific COVID-19 specimens they need for research using virtual biobanks. 9 Biobanks participating in the virtual COVID-19 biobanking network should be capable of processing, storing, and providing high-quality COVID-19 specimens to researchers across the globe. This is crucial for the success of the virtual biobanks.…”

Section: Introductionmentioning

confidence: 99%

Data Sharing Solutions for Biobanks for the COVID-19 Pandemic

Paul¹,

Chatterjee²

2020

Biopreservation and Biobanking

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) is a novel illness, which is not fully understood. Whether an individual has traveled outside their respective country or never left their community, COVID-19 is a highly contagious illness, which can result in high death rates. Biobanks will play a role in providing tools to examine data from those receiving treatment along with reviewing the current and long treatment outcomes associated with this novel coronavirus disease. A diverse, global network made up of laboratory scientists, clinical researchers, epidemiologists, data science teams, physicians, and so on must have a standardized, collaborative, virtual biobanking solution to share clinical expertise and evidence-based solutions. This virtual biobank must be centrally managed to ensure standardized quality assurance and quality control efforts. Virtual biobanks will eliminate the need to transport samples between two locations for a specific study, minimizing the risk of contamination. It is necessary for virtual biobanks to upload imaging data from those patients diagnosed with COVID-19. Standardized, collected information will be essential in the area of discovery and validation of disease markers as well as novel therapeutic strategies. It is essential for biobanks to collect COVID-19 specimens along with corresponding clinical and demographic data from COVID-19 diagnostic testing. Because COVID-19 is an acute respiratory illness, proper collection procedures must be in place to collect respiratory samples for biobanking purposes. A preconfigured purpose-built COVID-19 Laboratory Information Management System (LIMS) is an efficient tool to seamlessly manage a data sharing network. Data entered into LIMS will be beneficial in designing much needed clinical trials to address any unmet needs to better address clinical treatment and outcomes. The partners or entities associated with the COVID-19 data sharing network will be able to effectively communicate, view data, and images associated with their respective research interest to advance COVID-19 research and data driven, clinical care.

show abstract

Virtual global biorepository: access for all to speed-up result-oriented research

Cited by 4 publications

References 4 publications

Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine

Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine

The Andalusian Registry of Donors for Biomedical Research: Five Years of History

Data Sharing Solutions for Biobanks for the COVID-19 Pandemic

Contact Info

Product

Resources

About